03:45 AM EDT, 06/05/2025 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on June 02, 2025, sold 20,000 shares in Corcept Therapeutics ( CORT ) for $1,581,687. Following the Form 4 filing with the SEC, Maduck has control over a total of 117,398 common shares of the company, with 17,705 shares held directly and 99,693 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000095017025081933/xslF345X05/ownership.xml